ERD

ERDERA | EUROPEAN RARE DISEASES RESEARCH ALLIANCE

01-09-2024

-

31-08-2031

Show more information

Organisation BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL

TBVAC2020 | TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development

01-01-2015

-

30-06-2019

Show more information

Organisation BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL

EuroGCT | European consortium for communicating gene- and cell-based therapy information.

01-02-2021

-

31-01-2026

Show more information

Organisation BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL

Inno4Vac | Innovations to accelerate vaccine development and manufacture

01-09-2021

-

28-02-2027

Show more information

Organisation BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL

EU-PEARL | EU Patient- cEntric clinicAl tRial pLatform

01-11-2019

-

30-04-2023

Show more information

Organisation BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL

T2EVOLVE | Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy

01-01-2021

-

31-12-2025

Show more information

Organisation BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL

STARS | Strengthening training of academia in regulatory sciences and supporting regulatory scientific advice (STARS)

01-01-2019

-

30-06-2022

Show more information

Organisation BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL

imSAVAR | Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

01-12-2019

-

30-11-2025

Show more information

Organisation BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL

VAC2VAC | Vaccine lot to Vaccine lot comparison by consistency testing.

01-03-2016

-

28-02-2022

Show more information

Organisation BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL

ALLPreT | Allergenicity Prediction Toolbox for novel foods

01-09-2022

-

31-08-2026

Show more information

Organisation BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL

STACCATO | European Industrial Doctorate for enhancing upstream biopharmaceutical manufacturing process development through single cell analysis

01-01-2019

-

31-12-2022

Show more information

Organisation BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL

CCHFVaccine | Crimean-Congo Haemorrhagic Fever Vaccine

01-01-2017

-

31-12-2024

Show more information

Organisation BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL

CARAMBA | SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease

01-01-2018

-

30-06-2023

Show more information

Organisation BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL

T-OP | Training Network for Optimizing Adoptive T cell Therapy of Cancer

01-03-2021

-

28-02-2025

Show more information

Organisation BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL

COMBINE | Collaboration for Prevention and Treatment of MDR Bacterial Infections

01-11-2019

-

31-10-2025

Show more information

Organisation BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL

CARAT | Chimeric Antigen Receptors (CARs) for Advanced Therapies

01-01-2016

-

31-12-2019

Show more information

Organisation BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL

TIPAT | Training towards Personalized Antibiotic Treatment

01-03-2020

-

31-08-2024

Show more information

Organisation BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL

ECOWAS-RegECs | Practical strengthening of regulatory and ethics oversight on clinical trials in West Africa using Lassa Fever vaccine development projects and increase regulatory maturity level in targeted countries

01-06-2023

-

31-05-2025

Show more information

Organisation BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL

Projects overview

Selected filters:

ERDERA | EUROPEAN RARE DISEASES RESEARCH ALLIANCE

TBVAC2020 | TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development

EuroGCT | European consortium for communicating gene- and cell-based therapy information.

Inno4Vac | Innovations to accelerate vaccine development and manufacture

EU-PEARL | EU Patient- cEntric clinicAl tRial pLatform

T2EVOLVE | Accelerating Development and Improving Access to CAR and TCR-engineered T cell therapy

STARS | Strengthening training of academia in regulatory sciences and supporting regulatory scientific advice (STARS)

imSAVAR | Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies

VAC2VAC | Vaccine lot to Vaccine lot comparison by consistency testing.

ALLPreT | Allergenicity Prediction Toolbox for novel foods

STACCATO | European Industrial Doctorate for enhancing upstream biopharmaceutical manufacturing process development through single cell analysis

CCHFVaccine | Crimean-Congo Haemorrhagic Fever Vaccine

CARAMBA | SLAMF7-CAR T cells prepared by Sleeping Beauty gene-transfer for immunotherapy of multiple myeloma – a rare hematologic disease

T-OP | Training Network for Optimizing Adoptive T cell Therapy of Cancer

COMBINE | Collaboration for Prevention and Treatment of MDR Bacterial Infections

CARAT | Chimeric Antigen Receptors (CARs) for Advanced Therapies

TIPAT | Training towards Personalized Antibiotic Treatment

ECOWAS-RegECs | Practical strengthening of regulatory and ethics oversight on clinical trials in West Africa using Lassa Fever vaccine development projects and increase regulatory maturity level in targeted countries